Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hamilton-Miller, J. M.
Right arrow Articles by Shah, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton-Miller, J. M.
Right arrow Articles by Shah, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 39, 103-108, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy

ORIGINAL ARTICLES

Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin

JM Hamilton-Miller and S Shah
Department of Medical Microbiology, Royal Free Hospital School of Medicine, London, UK.

Bactericidal effects of quinupristin/dalfopristin and ciprofloxacin have been studied against six strains of Staphylococcus epidermidis, with varying erythromycin resistance phenotypes and varying abilities to form slime and adhere, growing as biofilms. Ciprofloxacin and quinupristin/dalfopristin killed (2-3 log10 cfu/mL) planktonic and sessile cells slowly, but progressively, over the course of 48 h. Rates of killing by quinupristin/dalfopristin were independent of concentration over the range 5-30 mg/L, and were somewhat slower than those seen with ciprofloxacin. These findings suggest that quinupristin/dalfopristin may be useful in the treatment of line- associated infections.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
R. CABRERA, J. RUIZ, M. RAMIREZ, L. BRAVO, A. FERNANDEZ, A. ALADUENA, A. ECHEITA, J. GASCON, P. L. ALONSO, and J. VILA
DISSEMINATION OF SALMONELLA ENTERICA SEROTYPE AGONA AND MULTIDRUG-RESISTANT SALMONELLA ENTERICA SEROTYPE TYPHIMURIUM IN CUBA
Am J Trop Med Hyg, June 1, 2006; 74(6): 1049 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. A. Rasmussen, S. A. Carlson, S. K. Franklin, Z. P. McCuddin, M. T. Wu, and V. K. Sharma
Exposure to Rumen Protozoa Leads to Enhancement of Pathogenicity of and Invasion by Multiple-Antibiotic-Resistant Salmonella enterica Bearing SGI1
Infect. Immun., August 1, 2005; 73(8): 4668 - 4675.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
W. A. Gebreyes and S. Thakur
Multidrug-Resistant Salmonella enterica Serovar Muenchen from Pigs and Humans and Potential Interserovar Transfer of Antimicrobial Resistance
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 503 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. A. Wu, C. Kusuma, J. J. Mond, and J. F. Kokai-Kun
Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3407 - 3414.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.